Profil
Neil Tristan Shahrestani is the founder of Ikarian Capital LLC, established in 2015, and holds the title of Chief Executive Officer.
Former jobs include Analyst at S.A.C.
Capital Advisors LP in 2013, Analyst at Goldman Sachs & Co. LLC.
from 2011 to 2013,.
and Senior Analyst at Pura Vida Investments LLC.
Education history includes an undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from Ross University School of Medicine, conferred in 2008.
Postes actifs de Neil Tristan Shahrestani
| Sociétés | Poste | Début |
|---|---|---|
Ikarian Capital LLC
Ikarian Capital LLC Investment ManagersFinance Ikarian seeks to generate consistently high, risk-adjusted returns for its clients that are uncorrelated to the broader market by employing a deep fundamental approach to identify investment themes across the biotechnology and pharmaceutical sub-sectors. Investments are selected through top-down screening and bottom-up due diligence which allow for comprehensive qualitative and quantitative assessment. | Directeur Général | 01/06/2022 |
Anciens postes connus de Neil Tristan Shahrestani
| Sociétés | Poste | Fin |
|---|---|---|
S.A.C. Capital Advisors LP
S.A.C. Capital Advisors LP Investment ManagersFinance S.A.C. Capital Advisors seeks to invest in the stocks of companies with short-term growth catalysts. The firm employs quantitative techniques and merger arbitrage strategies. | Analyst-Equity | 01/12/2013 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/01/2013 |
Pura Vida Investments LLC
Pura Vida Investments LLC Investment ManagersFinance Pura Vida employs a fundamentally driven investment approach that is focused on the healthcare sector. The firm uses a broad set of research tools in constructing its investment portfolios. They may, from time to time, make activist and/or control investments with respect to the issuer of an asset held in a client’s portfolio. Their investment strategies primarily involve trading equity and debt, both long and short, as well as derivatives of public and private issuers globally. | Analyst-Equity | - |
Formation de Neil Tristan Shahrestani
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
S.A.C. Capital Advisors LP
S.A.C. Capital Advisors LP Investment ManagersFinance S.A.C. Capital Advisors seeks to invest in the stocks of companies with short-term growth catalysts. The firm employs quantitative techniques and merger arbitrage strategies. | Finance |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ross University School of Medicine
Ross University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pura Vida Investments LLC
Pura Vida Investments LLC Investment ManagersFinance Pura Vida employs a fundamentally driven investment approach that is focused on the healthcare sector. The firm uses a broad set of research tools in constructing its investment portfolios. They may, from time to time, make activist and/or control investments with respect to the issuer of an asset held in a client’s portfolio. Their investment strategies primarily involve trading equity and debt, both long and short, as well as derivatives of public and private issuers globally. | Finance |
Ikarian Capital LLC
Ikarian Capital LLC Investment ManagersFinance Ikarian seeks to generate consistently high, risk-adjusted returns for its clients that are uncorrelated to the broader market by employing a deep fundamental approach to identify investment themes across the biotechnology and pharmaceutical sub-sectors. Investments are selected through top-down screening and bottom-up due diligence which allow for comprehensive qualitative and quantitative assessment. | Finance |
















